|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/337 | |
| A61K 31/4188 | |||
| A61K 31/506 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61P 43/00 |
| (11) | Number of the document | 2670405 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12706925.0 |
| Date of filing the European patent application | 2012-02-03 | |
| (97) | Date of publication of the European application | 2013-12-11 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2012/050513 |
| Date | 2012-02-03 |
| (87) | Number | WO 2012/104822 |
| Date | 2012-08-09 |
| (30) | Number | Date | Country code |
| PCT/IB2011/0504 | 2011-02-04 | WO |
| (72) |
REGENASS, Urs, CH
|
| (73) |
Actelion Pharmaceuticals Ltd.,
Gewerbestrasse 16, 4123 Allschwil,
CH
|
| (54) | COMBINATIONS COMPRISING MACITENTAN FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME |
| COMBINATIONS COMPRISING MACITENTAN FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME |